Literature DB >> 20110438

Plerixafor-moblized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier.

Monica S Thakar, Erlinda B Santos, Simon Fricker, Gary Bridger, Rainer Storb, Brenda M Sandmaier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20110438      PMCID： PMC2815512          DOI： 10.1182/blood-2009-09-245696

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study.

Authors:  Wolfgang A Bethge; D Scott Wilbur; Rainer Storb; Donald K Hamlin; Erlinda B Santos; Martin W Brechbiel; Brenda M Sandmaier
Journal:  Transplantation       Date:  2004-08-15       Impact factor: 4.939

2.  Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

Authors:  Robert E Donahue; Ping Jin; Aylin C Bonifacino; Mark E Metzger; Jiaqiang Ren; Ena Wang; David F Stroncek
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

3.  Characterization of monoclonal antibodies that recognize canine CD34.

Authors:  P A McSweeney; K A Rouleau; P M Wallace; B Bruno; R G Andrews; L Krizanac-Bengez; B M Sandmaier; R Storb; E Wayner; R A Nash
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

4.  Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.

Authors:  Takahiro Fukuda; Fabio R Kerbauy; Theodore Gooley; Erlinda B Santos; Rainer Storb; Brenda M Sandmaier
Journal:  Transplantation       Date:  2006-08-15       Impact factor: 4.939

5.  Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.

Authors:  Lauri Burroughs; Marco Mielcarek; Marie-Térèse Little; Gary Bridger; Ron Macfarland; Simon Fricker; Jean Labrecque; Brenda M Sandmaier; Rainer Storb
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

6.  DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.

Authors:  J L Wagner; J D Works; R Storb
Journal:  Tissue Antigens       Date:  1998-10

7.  Histocompatibility testing of dog families with highly polymorphic microsatellite markers.

Authors:  J L Wagner; R C Burnett; S A DeRose; L V Francisco; R Storb; E A Ostrander
Journal:  Transplantation       Date:  1996-09-27       Impact factor: 4.939

8.  Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction.

Authors:  Steven M Devine; Ravi Vij; Michael Rettig; Laura Todt; Kiley McGlauchlen; Nicholas Fisher; Hollie Devine; Daniel C Link; Gary Calandra; Gary Bridger; Peter Westervelt; John F Dipersio
Journal:  Blood       Date:  2008-04-21       Impact factor: 22.113

9.  Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils.

Authors:  P F Moore; P V Rossitto; D M Danilenko; J J Wielenga; R F Raff; E Severns
Journal:  Tissue Antigens       Date:  1992-08
  9 in total
  5 in total

Review 1.  Physiology and pharmacology of plerixafor.

Authors:  Simon P Fricker
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

Review 2.  Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.

Authors:  Y-J Chang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

3.  Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.

Authors:  Jeff Chang; Scott S Graves; Tiffany Butts-Miwongtum; George E Sale; Rainer Storb; David Woodbridge Mathes
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

4.  Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.

Authors:  Yun Chen; Takahiro Fukuda; Monica S Thakar; Brian T Kornblit; Barry E Storer; Erlinda B Santos; Rainer Storb; Brenda M Sandmaier
Journal:  Cytotherapy       Date:  2011-08-17       Impact factor: 5.414

5.  Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Authors:  Olivier Humbert; Frieda Chan; Yogendra S Rajawat; Troy R Torgerson; Christopher R Burtner; Nicholas W Hubbard; Daniel Humphrys; Zachary K Norgaard; Patricia O'Donnell; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Peter J Felsburg; David J Rawlings; Hans-Peter Kiem
Journal:  Blood Adv       Date:  2018-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.